AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MICROSAIC SYSTEMS PLC

Report Publication Announcement Mar 5, 2019

7786_rns_2019-03-05_6fb26588-67bb-43ad-8968-880086d1395b.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8042R

Microsaic Systems plc

05 March 2019

05 March 2019

Microsaic Systems plc

("Microsaic" or the "Company")

Investor Event

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments announces that it will be hosting an investor event on 11 March 2019.

The event will be held at Davy's at Woolgate Bar and Brasserie, 25 Basinghall St, London EC2V 5HA from 5.30pm and will take the form of a Company presentation to discuss the annual results followed by a Q&A session, finishing at 8.00pm.

The event is primarily aimed at the private client broker and retail investor communities.

Investors and shareholders who wish to attend the event should register their interest by visiting the link below:

https://www.eventbrite.com/o/microsaic-systems-plc-19343479112

Enquiries:
Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD
+44 (0) 1483 751 577
N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)
+44 (0)20 7496 3000
IFC Advisory Ltd (Financial PR)

Graham Herring

Heather Armstrong

Florence Chandler
+44 (0)20 3934 6630

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company works with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.  MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

The Microsaic's compact MiD® MS systems retain the functionality of larger conventional MS systems, while being easier to use by non-specialists, and consume less energy and have lower running costs. For more information, please go to www.microsaic.com.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NRAUSSBRKVAORAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.